Impact of Donor Heart Function on Recipient Outcomes
Official title: IMPact of Donor Heart Function on Recipient Outcomes - a prospectiVE Study to Increase the Utilization of Donor HEARTs
Run by Vastra Gotaland Region · NCT04393181 · Data updated 2026-11-12
This study looks at how the condition of donor hearts affects the recovery and health of people receiving heart transplants to see if using slightly damaged hearts can help more patients in need.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Gothenburg, Västra Götaland County) |
| Status | Recruiting |
| Started | April 5, 2022 |
| Main results expected | April 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | May 2, 2022 |
| Trial ID | NCT04393181 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 18 years or older who have been accepted for heart transplantation.
✕Probably not a fit
Patients with mental incapacity, language barriers, or those participating in conflicting studies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the effects of donor heart function on the outcomes of heart transplant recipients. It aims to determine whether donor hearts with functional impairments, which are often reversible, can be safely utilized for transplantation. By systematically assessing donor heart function, the study seeks to identify which hearts are suitable for transplant, potentially increasing the number of available donor organs for patients with severe heart failure. The study will include patients who have been accepted for heart transplantation at the participating center and will gather data on their outcomes post-transplant.
Why it matters
Potential benefit: If successful, this study could significantly increase the number of donor hearts available for transplantation, improving outcomes for patients with severe heart failure.
How similar studies have gone: While retrospective studies suggest that donor hearts with dysfunction can yield comparable outcomes to those with perfect function, this prospective approach is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient who has been accepted for heart transplantation at the participating transplantation center * The research subject has given written consent to participate in the study * Aged 18 years or older Exclusion Criteria: * • Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation * Another study, where the patient is included, which is not considered compatible with the current study.
Where it's running
-
Sahlgrenska University Hostpial
Gothenburg, Västra Götaland County, Sweden Recruiting
Study contacts
- Principal investigator: Göran Dellgren, MD, PhD — Vastragotalandsregionen, Sahlgrenska University Hospital,Gothenburg, Sweden
- Study coordinator: Jonatan Oras, MD, PhD
- Email: jonatan.oras@vgregion.se
- Phone: +46736370350
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nationwide Swedish program testing donor-derived cell-free DNA to monitor rejection after heart transplant
This project tests whether a blood test measuring donor-derived cell-free DNA can help monitor rejection in adults who have had a heart transplant.
-
Metabolic deterioration after heart transplant determines outcomes
We'll test whether worsening cardiac and systemic metabolism after a heart transplant predicts heart function and long-term survival in adult transplant recipients.
-
Mapping fat-cell sizes around the coronary arteries to trace inflammation
This project will test whether differences in fat-cell size next to the coronary arteries can show how inflammation spreads in people having a heart transplant for advanced heart failure.
-
Multimodal analysis of heart biopsy samples
This project will take one extra small heart biopsy during a clinically needed procedure to test whether detailed molecular and immune analyses can find disease-specific signatures in adults with cardiomyopathies, myocarditis, cardiac amyloidosis, or after heart transplant.
-
Long-term health of children born to mothers who had a solid organ transplant
This project will look for long-term heart, kidney, and immune system problems in people aged 16 and older who were born to mothers who had a kidney, liver, pancreas, heart, or lung transplant.
-
Cardiac rehabilitation cohort at Medicine Campus Davos to explore recovery
This project will follow adults coming to Hochgebirgsklinik Davos for cardiac rehabilitation to see how their heart health and recovery progress over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.